Pages that link to "Q39769715"

The following pages link to 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand (Q39769715):

Displaying 45 items.

• Vitamin D signaling in myogenesis: potential for treatment of sarcopenia (Q26849642) (← links)
• Structural considerations of vitamin D signaling (Q27022483) (← links)
• Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium (Q28550290) (← links)
• Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation (Q30425759) (← links)
• Vitamin D in Chronic Kidney Disease and Dialysis Patients (Q33616582) (← links)
• Association between Low Density Lipoprotein Receptor-Related Protein 2 Gene Polymorphisms and Bone Mineral Density Variation in Chinese Population (Q34103454) (← links)
• Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling (Q34146392) (← links)
• The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers (Q34396348) (← links)
• 25-hydroxyvitamin D₃ and 1,25-dihydroxyvitamin D₃ promote the differentiation of human subcutaneous preadipocytes (Q34526047) (← links)
• 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells (Q34717974) (← links)
• Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation (Q34974606) (← links)
• Gene expression profiles in human and mouse primary cells provide new insights into the differential actions of vitamin D3 metabolites (Q35014417) (← links)
• The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease (Q35119028) (← links)
• Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients (Q35124858) (← links)
• Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3. (Q35347547) (← links)
• Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes. (Q35543114) (← links)
• VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation (Q36175615) (← links)
• Peripubertal vitamin D(3) deficiency delays puberty and disrupts the estrous cycle in adult female mice (Q36200975) (← links)
• Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo (Q36729586) (← links)
• High Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals (Q37637890) (← links)
• 25-Hydroxyvitamin D3 induces osteogenic differentiation of human mesenchymal stem cells. (Q37648581) (← links)
• Vitamin D supplementation: a pharmacologic perspective (Q37803065) (← links)
• The immunoregulatory function of vitamin D: implications in chronic kidney disease (Q38012025) (← links)
• Novel metabolic biomarkers of cardiovascular disease (Q38245327) (← links)
• PTH and Vitamin D. (Q38804461) (← links)
• Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma (Q39004188) (← links)
• Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1. (Q39023042) (← links)
• Nano-encapsulation of vitamin D3 active metabolites for application in chemotherapy: formulation study and in vitro evaluation. (Q39229669) (← links)
• 25-Hydroxyvitamin D3 suppresses hepatitis C virus production (Q39367358) (← links)
• Drug-Mediated Gene Regulation of Vitamin D3 Metabolism in Primary Human Dermal Fibroblasts (Q39610128) (← links)
• The hypercalcaemia of CYP24A1 inactivation: new ways to improve diagnosis and treatment (Q42392761) (← links)
• Partial Rescue of the Phenotype in 1α-Hydroxylase Gene Knockout Mice by Vitamin D3 Injection (Q42750163) (← links)
• Three-step hydroxylation of vitamin D3 by a genetically engineered CYP105A1: enzymes and catalysis (Q42929108) (← links)
• Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D. (Q50347097) (← links)
• Ocular Pharmacokinetics of 25-Hydroxyvitamin D3 After Weekly Supplementation in Rabbits Using Ultra Performance Liquid Chromatography-Tandem Mass Spectrometer. (Q54248785) (← links)
• Biomarcadores de função endotelial em doenças cardiovasculares: hipertensão. (Q55266196) (← links)
• Without 1α-hydroxylation, the gene expression profile of 25(OH)D3 treatment overlaps deeply with that of 1,25(OH)2D3 in prostate cancer cells. (Q55468580) (← links)
• The serum vitamin D metabolome: What we know and what is still to discover (Q57159395) (← links)
• Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies (Q58768080) (← links)
• Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis (Q64116146) (← links)
• 25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism. (Q64965439) (← links)
• Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells (Q85337953) (← links)
• Joint effects of serum vitamin D insufficiency and periodontitis on insulin resistance, pre-diabetes, and type 2 diabetes: results from the National Health and Nutrition Examination Survey (NHANES) 2009-2010 (Q90726851) (← links)
• Generation of novel genetically modified rats to reveal the molecular mechanisms of vitamin D actions (Q90776248) (← links)
• Skeletal health, redox balance and gastrointestinal functionality in dairy cows: connecting bugs and bones (Q104134105) (← links)